Franco-Nevada Corporation · FNV · FY2025 Q4 · Calendar Q1 2026
Franco-Nevada: growth pipeline expands, execution risks remain
The evidence supports a constructive operating thesis: precious-metals exposure, acquired royalty assets, mine ramp-ups, and a debt-free balance sheet provide growth capacity. The thesis remains conditional on commodity prices, disciplined acquisitions, and execution on Cobre Panama and other development assets.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about FNV FY2025 Q4
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
The current analysis shifts the focus from a strong acquisition pipeline to delivery: acquired assets and ramp-ups are now central to the outlook, while Cobre Panama remains a material but uncertain source of additional growth.
Guidance delta
Management’s outlook is higher, with growth supported by newly acquired assets, mine ramp-ups, and potential Cobre Panama contributions.
Key takeaways
- The current call analysis points to a record performance period supported by precious-metals pricing and acquired assets.
- Management emphasized debt-free capital allocation, continued royalty and stream acquisitions, and dividend growth.
- The main upside case depends on mine ramp-ups, exploration optionality, and progress at Cobre Panama.
Management priorities
- Advance low-cost royalty and stream acquisitions.
- Support Bullabulling and the development of newly acquired assets.
- Maintain a debt-free balance sheet and progressive dividend policy.
- Use exploration on existing land packages to add future optionality.
Follow FNV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | Maintain | Nov 12, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 14, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| TD Cowen | Buy | Hold | Upgrade | May 20, 2026 |
| TD Securities | Hold | Hold | Maintain | Nov 5, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 10, 2025 |
| Barclays | Underweight | Underweight | Maintain | Jul 7, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Jul 18, 2022 |
| JP Morgan | Neutral | Neutral | Maintain | Mar 4, 2021 |
| Deutsche Bank | Hold | Hold | Maintain | Jun 17, 2020 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 8, 2019 |
| GMP Securities | Hold | Buy | Downgrade | Jul 23, 2019 |
| Dundee | Buy | Neutral | Upgrade | Dec 8, 2016 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 15, 2016 |
| Desjardins | Buy | Buy | Maintain | Oct 26, 2016 |
| National Bank Financial Inc | Sector Perform | Outperform | Downgrade | Oct 13, 2016 |
| National Bank FInancial | Sector Perform | Outperform | Downgrade | Oct 13, 2016 |
| BMO Capital | Market Perform | Outperform | Downgrade | May 12, 2016 |
| Goldman Sachs | Sell | Neutral | Downgrade | May 11, 2016 |
| Clarksons Platou | Buy | Buy | Maintain | Feb 16, 2016 |
| Macquarie | Outperform | Outperform | Maintain | May 14, 2015 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $223.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Fahad Tariq | $265 | $244.25 | +18.7% | Nov 12, 2026 |
| Scotiabank | Tanya Jakusconek | $274 | $202.32 | +22.8% | Jul 14, 2026 |
| RBC Capital | Analyst unavailable | $285 | $207.5 | +27.7% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $245 | $217.58 | +9.8% | Jul 6, 2026 |
| UBS | Daniel Major | $280 | $204.5 | +25.4% | Jun 30, 2026 |
| TD Securities | Analyst unavailable | $291 | $222.74 | +30.4% | May 20, 2026 |
| Scotiabank | Analyst unavailable | $290 | $237.11 | +29.9% | May 14, 2026 |
| H.C. Wainwright | Heiko Ihle | $305 | $265.72 | +36.6% | Mar 12, 2026 |
| H.C. Wainwright | Analyst unavailable | $285 | $250.65 | +27.7% | Feb 13, 2026 |
| UBS | Analyst unavailable | $310 | $242.45 | +38.9% | Jan 30, 2026 |
| Scotiabank | Analyst unavailable | $283 | $265.05 | +26.8% | Jan 26, 2026 |
| RBC Capital | Josh Wolfson | $250 | $202.93 | +12.0% | Dec 10, 2025 |
| Jefferies | Analyst unavailable | $228 | $203.17 | +2.1% | Dec 7, 2025 |
| UBS | Analyst unavailable | $270 | $208.1 | +21.0% | Dec 1, 2025 |
| H.C. Wainwright | Analyst unavailable | $210 | $185.14 | -5.9% | Nov 4, 2025 |
| Scotiabank | Tanya Jakusconek | $225 | $191.21 | +0.8% | Oct 23, 2025 |
| UBS | Daniel Major | $260 | $209.43 | +16.5% | Oct 16, 2025 |
| Raymond James | Analyst unavailable | $234 | $203.78 | +4.8% | Oct 10, 2025 |
| Raymond James | Brian MacArthur | $218 | $214.17 | -2.3% | Sep 23, 2025 |
| UBS | Daniel Major | $250 | $208.58 | +12.0% | Sep 19, 2025 |
| Raymond James | Brian MacArthur | $186 | $168.5 | -16.7% | May 28, 2025 |
| Scotiabank | Analyst unavailable | $150 | $145.74 | -32.8% | Mar 11, 2025 |
| TD Securities | Derick Ma | $152 | $145.74 | -31.9% | Mar 11, 2025 |
| Bank of America Securities | Lawson Winder | $139 | $124.46 | -37.7% | Oct 1, 2024 |
| Scotiabank | Tanya Jakusconek | $141 | $122.71 | -36.8% | May 23, 2024 |
| H.C. Wainwright | Analyst unavailable | $145 | $133.79 | -35.0% | Aug 11, 2022 |
| H.C. Wainwright | Analyst unavailable | $144 | $126 | -35.5% | Jul 19, 2022 |
| H.C. Wainwright | Analyst unavailable | $180 | $156.09 | -19.4% | May 5, 2022 |
| Industrial Alliance Securities | Puneet Singh | $187 | $130.35 | -16.2% | Jan 21, 2022 |
| KeyBanc | Adam Josephson | $154.38 | $134.33 | -30.8% | Dec 22, 2021 |
| Desjardins | John Sclodnick | $159.15 | $150.21 | -28.7% | May 20, 2021 |
Track every rating change on FNV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFranco-Nevada Corporation operates as a royalty and stream company focused on precious metals in South America, Central America, Mexico, the United States, Canada, Australia, Europe, and Africa. It operates through Precious Metals, Other Mining and Energy segments. The company manages its portfolio with a focus on precious metals, such as gold, silver, and platinum group metals; and engages in the sale of crude oil, natural gas, and natural gas liquids through a third-party marketing agent. The company was founded in 1986 and is headquartered in Toronto, Canada.
Historical context
All FNV earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SQM Sociedad Química y Minera de Chile S.A. | FY2026 Q3 · Calendar Q4 2026 | -3.0% | -5.5% | SQM Sees Lithium Demand Growth but Flags Price and Inventory Risks |
| CTA-PA EIDP, Inc. | FY2026 Q3 · Calendar Q3 2026 | +232.7% | — | New-product growth cushions EIDP, but Brazil weakness drives a lower outlook |
| CTA-PB EIDP, Inc. USD 4.50 Cum Pfd Registered Shs | FY2026 Q3 · Calendar Q3 2026 | — | — | New-product growth held up, but Brazil weakness cut the EBITDA outlook |
| VYLR Vylor Inc. | FY2026 Q3 · Calendar Q4 2026 | +21.1% | -0.1% | Vylor reaffirms 2026 outlook as Brazil licensing model shifts |
| CTVA Corteva, Inc. | FY2026 Q3 · Calendar Q4 2026 | +231.9% | -19.6% | Corteva Q3: New Products Grow as Brazil Weakness Cuts Outlook |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPFY2026 Q3 · November 16, 2026-3.0% EPS-2.5% move
Get the FNV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-02T19:46:12.287120+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-02T19:46:12.284041+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-02. For educational purposes only; not investment advice.